-
Most Recent
Search Results
240 results for cmo
Will ‘Sell in May and Go Away’ Take Hold in 2013 After All?
S&P 500 charts from the past decade illustrate why we shouldn’t start panicking about the recent market turbulence.
3 Small-Cap Dividend Stocks With Big Yields
Big, regular income checks plus a chance for share appreciation? Sounds like a winning combination to me.
Algorand Price Predictions: What’s Next for the ALGO Crypto?
Algorand (ALGO) price predictions are worth checking on Thursday as traders react to positive news concerning the crypto.
Why Is Pliant Therapeutics (PLRX) Stock Up 62% Today?
Pliant Therapeutics (PLRX) stock is taking off on Monday after releasing positive Phase 2a clinical trial data for bexotegrast.
Target Corporation: TGT Stock Is a Great Contrarian Play
Target has struggled this year, but restructuring and plans to expand online sales and grocery options could be just what TGT stock needs.
BNGO Stock: 9 Reasons Why Bionano Genomics Shares Are Getting a Boost Today
Bionano Genomics (BNGO) stock is on the rise Wednesday as investors react to news announced by the company after markets closed on Tuesday.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning, trader! It’s time to start off the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!
LCID Stock: Why Luxury EV Maker Lucid Is Running Out of Road
The Lucid Air is a billionaire’s electric ride, but there aren’t enough billionaires for Lucid to make a profit serving them.
The Secret Sauce Fueling Palantir Stock’s Meteoric Rise
Palantir stock has lost nearly 20% since hitting an all-time high in early March. It could be time to buy given its AIP platform’s growth.
The Biggest Myth In the Market Just Broke
The rally in AI stocks isn’t broadening — it’s concentrating. New data shows capital flowing into fewer winners across semiconductors and infrastructure.
Why Is Iovance Therapeutics (IOVA) Stock Down 45% Today?
Iovance Therapeutics (IOVA) stock is falling hard on Friday following the release of clinical trial data for its melanoma treatment.
IMMP Stock: Why Is Biotech Company Immutep Rocketing Higher Today?
Immutep Limited (IMMP) stock is soaring higher on Thursday despite a lack of recent news coming from the company but there is a reason why.
Why Is Tenax Therapeutics (TENX) Stock Up 149% Today?
Tenax Therapeutics (TENX) stock is rocketing higher on Thursday after getting an update on one of its U.S. medical patents.
Why Is Virios Therapeutics (VIRI) Stock Down 71% Today?
Virios Therapeutics (VIRI) stock is falling hard on Monday after revealing results from its Phase 2b study of IMC-1 in fibromyalgia.
A Solana NFT Vending Machine Gives SOL Crypto Fans Unique Opportunity
An NFT exchange is giving investors the opportunity to obtain Solana NFTs through a vending machine. Here’s what it means for SOL crypto.
VRTX Stock: The Disappointing News Sending Vertex Pharma Shares Lower
Vertex Pharma (VRTX) stock is dropping on Friday following the release of results from a Phase 2 clinical trial for VX-864.
No, Amazon and Uber Won’t Kill UPS and FedEx Stock (FDX, UPS)
Amazon and Uber won’t disrupt traditional logistics players FedEx or UPS, both boasting strong competitive advantages for the long haul.
3 Super-Duper Dividend ETFs
These dividend ETFs have dividend yields that are well above the average, and because they’re diversified funds, they offer safety to boot.
What This Week’s Earnings Really Tell Us About AI
Iran talks stall and oil climbs… the real question inside Big Tech earnings… why the Mythos breach changes things… and what it means for your…
PayPal Stock Is Up 34% From Its 5-Year Low. It’s Time to Buy.
After several years in the wilderness, PYPL stock appears to be returning to investors’ favor, which is good news for long-time shareholders.
8 – 10 of 240 results
